Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 4/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.41 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.41 |
| ▸ | HIPK2 | Q9H2X6 | 2/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.41 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | BTK | Q06187 | 3/20 | 0.41 |
| ▸ | KDR | P35968 | 4/20 | 0.40 |
| ▸ | LYN | P07948 | 3/20 | 0.38 |
| ▸ | SYK | P43405 | 3/20 | 0.38 |
| ▸ | PLK4 | O00444 | 1/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | PAK4 | O96013 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14633944 | 0.93 | BTK (0.45) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| Trifluoroacetic Acid SCHEMBL14634212 | 0.93 | GRM4 (0.43) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| Trifluoroacetic Acid SCHEMBL14634066 | 0.93 | BTK (0.41) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| Trifluoroacetic Acid SCHEMBL14634177 | 0.89 | RIPK2 (0.44) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| Trifluoroacetic Acid SCHEMBL14634114 | 0.87 | GRM4 (0.43) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| Trifluoroacetic Acid SCHEMBL14633769 | 0.86 | EPHB4 (0.53) | CDK2MAPK8GSK3BHIPK2CLK4 | |
| SCHEMBL14633980 | 0.84 | BTK (0.43) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| SCHEMBL2516402 | 0.84 | EPHB4 (0.39) | AURKACDK2AURKBBTKKDR | |
| Trifluoroacetic Acid SCHEMBL14634188 | 0.82 | GRM4 (0.49) | AURKAMAP4K4CDK2MAPK8GSK3B | |
| SCHEMBL14634174 | 0.81 | RIPK2 (0.49) | GSK3BBTKKDRLYNSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130023532-A1 | INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023532-A1 | INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS | MAP3K19, MAP3K1, MAP3K20 | AURKA 70/4885MAP4K4 33/4885CDK2 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.